Allogeneic bone marrow transplantation in adrenoleukodystrophy

Clinical, pathologic, and biochemical studies

Andrew M Yeager, H. W. Moser, P. J. Tutschka, R. Saral, A. A. Kumar, G. W. Santos

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The biochemical defect in ALD is due to impaired oxidation of VLCFA within the peroxisomes, subcellular organelles in which a wide range of activities occur, including β-oxidation of long-chain fatty acids and synthesis of bile acids and glycerolipids. The observation that normal leukocytes can oxidize VLCFA, and the encouraging clinical reports of allogeneic bone marrow transplantation (BMT) for various lysosomal storage diseases, along with the lack of other therapeutic options, led us to perform BMT in a 12 1/2 -year-old boy with rapidly progressive ALD. In this report we describe the clinical course and the biochemical and neuropathologic findings in our patient after allogeneic BMT from an unaffected normal MHC-matched brother.

Original languageEnglish (US)
Pages (from-to)79-100
Number of pages22
JournalBirth Defects: Original Article Series
Volume22
Issue number1
StatePublished - 1986
Externally publishedYes

Fingerprint

Adrenoleukodystrophy
Homologous Transplantation
Bone Marrow Transplantation
Lysosomal Storage Diseases
Peroxisomes
Bile Acids and Salts
Organelles
Siblings
Leukocytes
Fatty Acids
Therapeutics

ASJC Scopus subject areas

  • Genetics(clinical)
  • Developmental Biology

Cite this

Allogeneic bone marrow transplantation in adrenoleukodystrophy : Clinical, pathologic, and biochemical studies. / Yeager, Andrew M; Moser, H. W.; Tutschka, P. J.; Saral, R.; Kumar, A. A.; Santos, G. W.

In: Birth Defects: Original Article Series, Vol. 22, No. 1, 1986, p. 79-100.

Research output: Contribution to journalArticle

Yeager, Andrew M ; Moser, H. W. ; Tutschka, P. J. ; Saral, R. ; Kumar, A. A. ; Santos, G. W. / Allogeneic bone marrow transplantation in adrenoleukodystrophy : Clinical, pathologic, and biochemical studies. In: Birth Defects: Original Article Series. 1986 ; Vol. 22, No. 1. pp. 79-100.
@article{ab0f6b7c7f9647b29f87bc4b2386f302,
title = "Allogeneic bone marrow transplantation in adrenoleukodystrophy: Clinical, pathologic, and biochemical studies",
abstract = "The biochemical defect in ALD is due to impaired oxidation of VLCFA within the peroxisomes, subcellular organelles in which a wide range of activities occur, including β-oxidation of long-chain fatty acids and synthesis of bile acids and glycerolipids. The observation that normal leukocytes can oxidize VLCFA, and the encouraging clinical reports of allogeneic bone marrow transplantation (BMT) for various lysosomal storage diseases, along with the lack of other therapeutic options, led us to perform BMT in a 12 1/2 -year-old boy with rapidly progressive ALD. In this report we describe the clinical course and the biochemical and neuropathologic findings in our patient after allogeneic BMT from an unaffected normal MHC-matched brother.",
author = "Yeager, {Andrew M} and Moser, {H. W.} and Tutschka, {P. J.} and R. Saral and Kumar, {A. A.} and Santos, {G. W.}",
year = "1986",
language = "English (US)",
volume = "22",
pages = "79--100",
journal = "Birth Defects: Original Article Series",
issn = "0547-6844",
publisher = "March of Dimes Birth Defects Foundation",
number = "1",

}

TY - JOUR

T1 - Allogeneic bone marrow transplantation in adrenoleukodystrophy

T2 - Clinical, pathologic, and biochemical studies

AU - Yeager, Andrew M

AU - Moser, H. W.

AU - Tutschka, P. J.

AU - Saral, R.

AU - Kumar, A. A.

AU - Santos, G. W.

PY - 1986

Y1 - 1986

N2 - The biochemical defect in ALD is due to impaired oxidation of VLCFA within the peroxisomes, subcellular organelles in which a wide range of activities occur, including β-oxidation of long-chain fatty acids and synthesis of bile acids and glycerolipids. The observation that normal leukocytes can oxidize VLCFA, and the encouraging clinical reports of allogeneic bone marrow transplantation (BMT) for various lysosomal storage diseases, along with the lack of other therapeutic options, led us to perform BMT in a 12 1/2 -year-old boy with rapidly progressive ALD. In this report we describe the clinical course and the biochemical and neuropathologic findings in our patient after allogeneic BMT from an unaffected normal MHC-matched brother.

AB - The biochemical defect in ALD is due to impaired oxidation of VLCFA within the peroxisomes, subcellular organelles in which a wide range of activities occur, including β-oxidation of long-chain fatty acids and synthesis of bile acids and glycerolipids. The observation that normal leukocytes can oxidize VLCFA, and the encouraging clinical reports of allogeneic bone marrow transplantation (BMT) for various lysosomal storage diseases, along with the lack of other therapeutic options, led us to perform BMT in a 12 1/2 -year-old boy with rapidly progressive ALD. In this report we describe the clinical course and the biochemical and neuropathologic findings in our patient after allogeneic BMT from an unaffected normal MHC-matched brother.

UR - http://www.scopus.com/inward/record.url?scp=0022875844&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022875844&partnerID=8YFLogxK

M3 - Article

VL - 22

SP - 79

EP - 100

JO - Birth Defects: Original Article Series

JF - Birth Defects: Original Article Series

SN - 0547-6844

IS - 1

ER -